Posters recently presented by ARI scientists, listed below in reverse chronological order, may be viewed as PDF files.
14th Conference on Retroviruses and Opportunistic Infections
Los Angeles, CA, February 25–28, 2007
Aweeka FT, Stek A, Best B, Hu C, Holland D, Hermes A, Burchett S, Read J, Mirochnick M, Capparelli EV for the P1026s team.
Lopinavir protein binding during pregnancy.
Aweeka FT, Tierney C, Stek A, Sun X, Cohn SE, Coombs R, Lizak P, Kmack AM, Klingman K, and
Sha BE for the ACTG 5153s team. ACTG A5153s, a substudy for A5150: Pharmacokinetic exposure and virological response in HIV-1–infected pregnant
women treated with protease inhibitors.
Baum PD and McCune JM. AmpliCot: A novel method for measuring T cell receptor diversity.
Beatty G, Chow L, Lipshutz G, Pillai S, Hoh R, Spotts G, Martin J, Deeks SG, Liegler T.
HIV-1 from seminal fluid exhibits stable high-levels of drug resistance mutations in patients maintained on incompletely suppressive antiretroviral regimens.
Bragg L, McConnell JJ, Delwart E, Herring B, Kreis C, and Grant RM. Antiretroviral treatment (ART) may reduce but did not eliminate exposure to possible superinfection.
Butler L, Mosam A, Kiepiela P, Rosenthal1 P, Dorsey G, Mbisa G, Whitby D, Brander C, Scadden D,
Dollard S, Martin J. Lack of age dependence in KSHV seroprevalence among children in a population-based study in South Africa:
Evidence for at least two epidemiologic patterns of KSHV transmission in Africa.
Emu B, Sinclair E, Shacklett B, Ferre A, Hoh R, Hatano H, Martin J, McCune JM, and DeeksS. High levels of gag-specific CD8+
IFNγ+ IL-2+T cell response are correlated with the expression of protective HLA types among HIV-infected virologic
controllers.
German P, Greenhouse B, Coates C, Dorsey G, Rosenthal P, Charlebois E, Lindegardh N, Havlir D, and Aweeka F. Drug interaction between antimalarial drugs and efavirenz.
Hatano H, Morris M, Ferre A, Williamson DW, Hoh R, McCune JM, Martin JN, Shacklett
BL, and Deeks SG. Genetic determinants of durable control of HIV replication in the absence of antiretroviral therapy.
Hecht F, Wellman R, Busch M, Little S, Markowitz M, Collier A, Margolick J, Norris P,
Routy J-P, Holte S, and the Acute Infection Early Disease Research Program. Use of quantitative results from HIV antibody EIAs to identify
persons in early post-seroconversion periods.
Hunt PW, Cao H, Martin JN, Baker C, Jones N, Ssewanyana I, Andia I, Emenyonu N, Bangsberg DR,
and Deeks SG. Untreated HIV-infected individuals in Uganda have higher CD8+ T cell activation levels than untreated HIV-infected individuals
in North America.
Hunt PW, Huang W, Coakley E, Petropoulos C, Bates M, Hoh R, Deeks SG, and Martin JN.
Longitudinal evaluation of viral co-receptor tropism switches among HIV-infected patients with drug-resistant viremia.
Ladell K, Cesar D, Boban D, Hunrichs B, Hellerstein M, and McCune JM. Phenotypic, kinetic,
and molecular characterization of long-lived (“memory”) CD8+ T cells in healthy and HIV-infected subjects.
Luetkemeyer A, Charlebois ED, Flores LL, Bangsberg DR, Deeks SG, Martin JN, Havlir DV1.
Comparison of an interferon gamma release assay to conventional tuberculin skin testing for latent TB diagnosis in HIV-infected individuals.
Martin J, Neilands T, Krone M, Coakley E, Lie Y, Pesano R, Bates M, Weidler J, and Deeks S.
Utility of pol replication capacity in predicting immunologic course among HIV-infected patients with drug-resistant viremia.
Petersen ML, Wang Y, van der Laan MJ, Guzman D, Riley E, and Bangsberg DR. Pill box organizers are associated with improved HIV antiretroviral
adherence and viral suppression: A marginal structural model analysis.
Roland M, Barin B, Wong M, Keller M, Ragni M, Hardy D, Blumberg E, Feinberg J, Stablein D, and
Stock P. HIV RNA suppression following liver and kidney transplantation.
Ruel TD, Achan J, Gasasira AF, Charlebois ED, Rosenthal PJ, Dorsey G, Kamya MR, Kekitiinwa A, Wong J, Havlir D, and the CHAMP team. Dramatic reductions in HIV RNA among HIV-infected children with acute measles in Uganda.
Salemi M, Galligan DC, Lamers S, de Oliveira T, Zhao L, McGrath MS. Extensive intra-patient recombination within HIV-1 env gp120 genes sampled from different tissues.
Sohn AH, Quoc Thinh, Xuan Lien T, Truong Giang L, Huu Khanh T, Wara DW, Cachafeiro A, Rutherford
GW. The ultrasensitive p24 antigen assay is comparable to DNA PCR for early infant diagnosis, Ho Chi Minh City, Vietnam.
Srikantiah P, Walusimbi M, Kose Kayanja H, Mayanja-Kizza H, Mugerwa RD, Lin R, Charlebois
ED, Boom WH, Whalen CC, Havlir DV. Safety and early virologic response of zidovudine/lamivudine/abacavir for patients co-infected with HIV and
tuberculosis (TB) in Uganda.
Srikantiah P, Walusimbi M, Mayanja-Kizza H, Kose Kayanja H, Mugerwa RD, Harvey RA,
Charlebois ED, Boom WH, Whalen CC, Havlir DV. Unexpected low-level viremia among HIV-infected Ugandans with untreated active tuberculosis (TB).
Truong H-HM, Fritz K, McFarland W, Hartogensis W, Fiamma A, Coates TJ, and Morin SF. Recent HIV infections detected at a mobile VCT program
in Zimbabwe.
Truong H-HM, Kellogg T, Louie B, Klausner J, Dilley J, and McFarland W. Comparison of incidence estimates derived by laboratory incidence assays
and repeat testing data at HIV testing sites in San Francisco.
17th International Conference on the Reduction of Drug Related Harm
Vancouver, Canada, April 30–May 4, 2006
Axelson P, Davidson P, Lum P, Page-Shafer K. UFO clinical care for young street-based drug injectors.
Ford JL, Paciorek A, Hahn JA, Page Shafer K, Lum PJ. Willingness to participate in preventive HIV vaccine trials among young IDU: The UFO VAX Study.
Hahn J, Colfax G, Moss A, Bangsberg D. Quadrupling of methamphetamine use among homeless and marginally
housed persons, 1996–2003.
Hahn J, Lum P, Evans J, Davidson P, Page Shafer K. Hepatitis C virus serosorting among young IDU
(The UFO Study).
Pete Morse, Jamye Ford, Peter Davidson, Judy Hahn, Paula Lum, Kimberly Page-Shafer. Negotiating contradictions
between research and service goals at the UFO Study.
Page-Shafer K, Evans J, Lum P, Davidson P, Hahn J. Temporal trends in methamphetamine use among young injectors
in San Francisco (1998 to 2004): The UFO Study.
National Conference on Methamphetamine, HIV, and Hepatitis
Salt Lake City, UT, August 18–21, 2005
Vaudrey J, Raymond HF, Jain S, McFarland W. Methamphetamine use among men who have sex with men (MSM)
in San Francisco: Who is at risk for HIV acquisition?
NIDA Annual Mentored K Awardees Meeting
Bethesda, MD, August 2–4, 2005
Colfax G, Coates TJ, Husnik MH, Huang Y, Buchbinder S, Koblin B, Chesney M,
Vittinghoff E, and the EXPLORE study team. Longitudinal patterns of methamphetamine, amyl nitrite, and cocaine
use among a cohort of men who have sex with men.
HIV Prevention Leadership Summit
San Francisco, CA, July 30–August 3, 2005
Fuqua V, Imbriani J, Macias O, Sebesta D. Locally-developed innovative strategies
to increase social capital and to foster community building among Black, Latino, Asian, older, midlife, and queer
youth gay men.
3rd IAS Conference on HIV Pathogenesis and Treatment
Rio de Janiero, Brazil, July 24–27, 2005
Chin-Hong PV, Deeks SG, Liegler T, Grant RM, Hecht FM, Vittinghoff E,
Coates TJ, Martin JN. Methamphetamine use is associated with potential sexual transmission of drug-resistant HIV.
Chin-Hong PV, Vittinghoff E, Benet D, Buchbinder S, Colfax G,
Cranston R, Da Costa M, Darragh T, Judson F, Koblin B, Mayer K, Palefsky J. Human papillomavirus is associated with
HIV acquisition: The EXPLORE study.
McGrath MS, Lamers SL, Salemi M. HIV sequence evolution in the brain:
Distinctly different evolutionary pathways between HAD and primary CNS lymphoma associated strains of HIV.
Rose V. The Breakfast Buffet: Late night harm reduction services for injection drug using MSM.
Snyder-Cappione JE, Divekar AA, Maupin GM, Jin X, Demeter LM, Mosmann TR.
HIV-specific cytotoxic cell frequencies measured directly ex vivo by the Lysispot assay can be higher or lower than
the frequencies of IFNg-secreting cells: Anti-HIV cytotoxicity is not generally impaired relative to other chronic virus
responses.
Truong H-HM, Kellogg T, Schwarz S, Delgado V, Grant R, McFarland W.
International HIV mobility: Implications for the sexual spread of antiretroviral drug resistance among MSM.
National Medical Association Scientific Assembly and Annual Conference
New York, NY, July 23–28, 2005
Mahoney M, Sterkenburg C, Goldschmidt R. African American clinicians providing
HIV care: Experience of the National Clinicians’ HIV Telephone Consultation Service Warmline.
16th Biennial Meeting of the International Society for Sexually Transmitted Diseases Research
Amsterdam, Netherlands, July 10–13, 2005
Harrison WG, Kinyari T, Meier A, Brunham R, Nguti R, Mugo NR, Cohen CR. Risk
factors for Neisseria gonorrhoeae in a prospective cohort of Kenyan female sex workers.
Kinyari TN, White E, Sharma A, Morris M, Bukusi EA, Meier A, Farquhar C, Ngugi EN,
Cohen CR. The relationship between sexual partnership characteristics and condom use among young female sex workers in
Nairobi, Kenya.
Nguti R, Mugo N, Kwatampora J, Kimani P, Muthama E, Cohen C. Factors associated
with behaviour change and time to infection with Neisseria gonorrhoeae and Chlamydia trachomatis in an observational
cohort of sex workers in Nairobi, Kenya.
Ondondo B, Brunham R, Sheth P, Kinyari T, Nguti R, Mugo N, Cohen CR. Mucosal immune
responses to C. trachomatis in the endometrium are directed to the heat shock protein 60.
Van der Straten A, Lee M, Montgomery E, Blanchard K, Ramjee G, De Bruyn G,
Padian N. Characteristics of non-disclosers of diaphragm use among Southern African women enrolled in an HIV prevention
trial.
7th International Congress on AIDS in Asia and the Pacific
Kobe, Japan, July 1–5, 2005
Choi K-H, Ning Z, Liu JX, Gregorich S, Pan Q-C. Social networks and HIV/syphilis
infections among men who have sex with men, Shanghai.
Do TD, Choi K-H, Hudes ES, Proctor K, Han CS. HIV testing: Trends and correlates among
young Asian and Pacific Islander men who have sex with men in two U.S. cities.
Nemoto T, Iwamoto M, Lee P, Chang W, Tam C, Sacramento N, Will S, Sakakibara K, Espejo P.
Community outreach to high-risk Asian and Pacific Islanders (APIs).
Phuong TVA, Colby DJ, Bain-Brickley D, Thinh T, Trung NV, Mandel JS. Training HIV
counselors about MSM in Vietnam.
Vezina R, Reyes EM, Goshima C, Morin SF. Building HIV clinical capacity: Lessons from
the US-affiliated Pacific Jurisdictions Project.
National HIV Prevention Conference
Atlanta, GA, June 12–15, 2005
DeCarlo P, Warren M, Adler N, Goldstein E, Arjona M, Bernstein J, Stumbo S, Grinstead O.
HIV Prevention Fact Sheets help put science into practice.
Kennedy GE, Horváth T, Rutherford GW. Assessing the evidence for HIV prevention
strategies.
Steward WT, Morin SF, Charlebois ED, Johnson MO, Kelly JA, Remien RH, Rotheram-Borus MJ.
HIV-infected MSM are less likely to receive prevention services despite greater risks of HIV transmission.
XIV International HIV Drug Resistance Workshop
Quebec City, Quebec, June 7–11, 2005
Chin-Hong PV, Deeks SG, Liegler T, Krone MR, Grant RM, Hecht FM, Vittinghoff E,
Coates TJ, Martin JN. Methamphetamine use is associated with ongoing high-risk sexual behaviors among HIV-infected
individuals with drug-resistant virus.
2nd South African AIDS Conference
Durban, South Africa, June 7–10, 2005
Napierala S, Van der Straten A, Lee M, Hammond N, Padian N. High prevalence of
reproductive tract infection in women screened for a diaphragm and microbicide safety trial in Harare, Zimbabwe.
American Psychological Society Meeting
Los Angeles, CA, May 26–29, 2005
Dolcini MM, Harper GW, Boyer CB, Catania JA, Watson SE. Project ÒRÉ: A social
psychological approach to HIV/STI interventions and outcome construction.
American Thoracic Society International Conference
San Diego, CA, May 20–25, 2005
Chi A, Beard CB, Crothers K, Jones J, Groner G, Fox M, Eiser S, Bensley M, Huang L.
HIV-associated Pneumocystis pneumonia (PCP) with mixed dihydropteroate synthase (DHPS) genotype infection: Predictors
and outcomes.
Hernandez J, Bensley M, Chi A, Huang L. HIV-associated Pneumocystis pneumonia (PCP)
in the era of combination antiretroviral therapy: Decline in the sensitivity of sputum induction.
Huang L, Welsh D, Miller R, Bensley M, Carbonnet D, Fox M, Groner G, Chi A, Eiser S,
Beard CB, Jones J. Pneumocystis dihydropteroate synthase (SHPS) gene mutations and mortality of HIV-associated Pneumocystis
pneumonia (PCP).
3rd International ISPO (International Society of Perinatal Obstetricians) Conference
Dublin, Ireland, May 19–21, 2005
Ojengbede OA, Miller S, Anderson A, Fabamwo O, Akinol OA, Morhason-Bello IO, Hensleigh P.
Novel approach in management of severe obstetric hemorrhage: Nigeria hospital experience with the non-pneumatic anti-shock
garment (NASG).
American Society of Clinical Oncology Annual Meeting
Orlando, FL, May 13–17, 2005
Bhatia V, Roldan E, Moore DH, Hanks D, Cheng J, Lane K, Benz C, Knudson M, Luce J. Estrogen
receptor positivity improves breast cancer survival for all underserved ethnic groups except African Americans.
San Francisco State University College of Science and Engineering Student Showcase
San Francisco, CA, May 9, 2005
Lai Hipp C, Leong M, Scott EP, Vyas GN. Optimal expansion of HIV-1 field isolates using human
CD4+cell substrate derived from selected blood donors.
American College of Obstetricians and Gynecologists Annual Clinical Meeting
San Francisco, CA, May 7–11, 2005
DePiñeres T, Blumenthal PD, Diener-West M. Postpartum contraception: A review of the New
Mexico Pregnancy Risk Assessment Monitoring System (PRAMS).
ARVO (Association for Research in Vision and Ophthalmology) 2005: Global Networking
Ft. Lauderdale, FL, May 1–5, 2005
Haidt SJ, Gascon R, Zhang R, Stern W, Wieland M, Boldrey E, Palmer J, Borrillo L, McGrath M.
Blood monocyte expression levels of HLA-DR and CD16 are markers of disease progression in age-related macular degeneration (ARMD).
22nd International Papillomavirus Conference and Clinical Workshop
Vancouver, BC, April 30–May 6, 2005
Chin-Hong PV, Vittinghoff E, Benet D, Buchbinder S, Colfax G, Cranston R, Da Costa M, Darragh T,
Judson F, Koblin B, Mayer K, Palefsky J. Age-related incidence of anal human papillomavirus infection among sexually active men who
have sex with men: The EXPLORE study.
Huebner DM, Chin-Hong PV. Awareness and utilization of anal cytology screening among men who have
sex with men.
Sawaya G, Tuveson J, Rubin M, Da Costa M, Darragh T, Shiboski S, Van der Pol B, Moscicki A,
Palefsky J, Fancher H, Smith-McCune K. Does Replens vaginal gel interfere with tests for human papillomavirus and other lower
genital tract infections?
12th International Workshop on HIV Dynamics and Evolution
Cleveland, OH, April 23–26, 2005
Salemi M, Lamers SL, Yu S, de Oliveira T, Fitch WM, McGrath MS. Phylodynamic analysis of HIV-1 in
the brain.
Association of Nurses in AIDS Care Research Summit
Palm Springs, CA, April 22–24, 2005
Dawson Rose C, Pearson C, Mackenzie S, Pelegrino C, Knight K. Community agencies and their link
to HIV prevention.
Keystone Symposia: HIV Pathogenesis and HIV Vaccines—Current Challenges and Future Prospects
Banff, Alberta, April 9–15, 2005
Karlsson AC, Chapman JM, Davenport M, Spotts G, Martin JN, Deeks SG, Hecht FM, Nixon DF. Early HIV
escape from HLA-A2-restricted CTL responses is associated with loss of viral control.
Karlsson AC, Chapman JM, Martin JN, Kallas EG, Hecht FM, Deeks SG, Nixon DF. Diversity of epitope
and cytokine profiles at different stages of HIV-1 infection.
Legrand FA, Jordan KA, Loo CP, Rosenberg MG, Wiznia AA, Nixon DF. Divergent immune responses in HIV-1
vertically infected monozygotic twins.
Owen RE, Deeks SG, Sinclair E, Emu B, Barbour J, Spotts G, Heitman H, Hoh R, Martin J, Bredt B, Hecht F,
Norris PJ. Defining immune correlates of protection: HIV-specific CD4+ cytotoxic T cells.
Schweighardt B, Legrand F, Meiklejohn DA, Erickson A, Spotts G, Emu B, Nixon DF, Hecht FM. The
development of immune escape mutations within immunodominant Gag epitopes is associated with increased viral replication during structured
treatment interruption.
Snyder-Cappione JE, Divekar AA, Maupin GM, Jin X, Demeter LM, Mosmann TR. The Lysispot assay reveals
HIV-specific T cells can lyse targets without secreting IFNg directly ex vivo, and the frequencies of IFNg-secreting to cytotoxic cells
vary both amongst HIV-specific and in comparison to CMV, EBV responses within individual patients.
7th Annual International Health Conference
San Francisco, CA, April 2, 2005
Bray E, Lester F, Miller S, Hensleigh P. New advances for controlling obstetric hemorrhage: A pilot study
of the non-pneumatic anti-shock garment (NASG) in Egypt.
Madhivanan P, Jerajani H, Mathur M, Gogate A, Lindan C. Sexual behavior and STIs among men at high
risk for HIV infection in Mumbai, India.
Population Association of America Annual Meeting
Philadelphia PA, March 31–April 2, 2005
Montagu D, Prata N, McPherson R, Tamang A. Provider networks and quality of care for reproductive health
services in Nepal.
Pathways to Research: A Day of Discovery
San Francisco, CA, March 2, 2005
Brenot A, Köhler G, Agabian N. Prostaglandin biosynthesis in Candida albicans.
12th Conference on Retroviruses and Opportunistic Infections
Boston, MA, February 22–25, 2005
Bangsberg DR, Weiser SD, Guzman D, Riley ED. 95% adherence is not necessary to suppress the
majority of individuals to less than 400 copies/ml on NNRTI regimens.
Byakika-Tusiime, J, Oyugi J, Musoke P, Ragland K, Bangsberg DR. Adherence approaches 100% with
excellent viral load suppression when all HIV infected household members receive antiretroviral treatment.
Fogler J, Mahoney M, Sterkenburg C, Cohan D, Gooze L, Kindrick A, Balano K, Thelin C, Alexander D,
Goldschmidt R. Clinicians’ questions about perinatal HIV transmission and perinatal care: Experience of the national HIV telephone consultation
service and perinatal hotline.
Gandhi M, Jayawardene A, Aweeka F, Bacchetti P, Ameli N, Cohen M, Gange S, Anastos K, Young M, Holman S,
Greenblatt RM. Determination of antiretroviral exposure using hair: A measure of average exposure highly correlated with virologic outcome.
Grant RM, McConnell JJ, Marcus JL, Kreis C, Spotts G, Liegler T, Brennan R, Hecht FM. Higher frequency
of apparent HIV-1 superinfection—sequentially expressed dual infection (SEDI)—in recent infection compared to chronic infection.
Roland M, Myer L, Chuunga R, Martin L, Maw A, Coates T, Denny L. A prospective study of post-exposure
prophylaxis following sexual assault in South Africa.
Roland M, Stablein D, Carlson L, Frassetto L, Murphy B, Keller M, Olthoff K, Blumberg E, Brayman K,
Redfield R, Oldach D, Barin B, Stock P. 1- to 3-year outcomes in HIV-infected liver and kidney transplant recipients.
Salemi M, Lamers SL, Yu S, de Oliveira T, Fitch WM, McGrath MS. Photodynamic analysis of HIV-1 in the brain.
Truong HM, Fritz K, Woelk G, Chirowodza A, Makumbe K, Evans J, McFarland W. HIV prevalence and risk
behaviors remain stable among men at Harare beerhalls.
Young TP, Lee A, Roark R, Cohan D, Hanks D, Ung R, Jeffalone M, Stansell J, Hare CB. Cervical and anal
Pap smear correlation among HIV infected women.
National Conference on West Nile Virus in the U.S.
San Jose, CA, February 8–9, 2005
Busch MP, Tobler LH, McAuley J, Linnen JM, Shyamala V, Robertson GF, Wright DJ, Kleinman SK, Caglioti S. West Nile
virus RNA dynamics and antibody evolution based on follow-up of viremic blood donors.
Busch MP, Wright DJ, Tobler LH, Stramer SL, Custer BS, Kleinman SH, Prince HE, Bianco C, Foster G, Petersen LR,
Nemo GJ, Glynn SA. West Nile virus (WNV) infections detected by blood donor nucleic-acid amplification technology (NAT) screening and use of NAT
data to project national WNV infections in 2003.
Caglioti S, Robertson GF, McAuley J, Kleinman SH, Tobler LH, Kamel H, Linnen JM, Shyamala V, Tomasulo PA, Busch MP.
Screening the blood supply for West Nile virus RNA by nucleic acid amplification testing (NAT).
Herring B, Bernardin F, Tobler L, Williams A, Cheng L, Rampersad S, Cameron C, Saldanha J, Busch M, Delwart E.
Phylogenetic analysis of WNV in North American blood donors during 2003–2004.
Tobler LH, Prince H, Valks A, Dille B, Andrews WW, Harrington C, Phelps BH, Munneke B, Morgan L, Ostboe P,
Gefter N, Busch MP. Relative performance of four West Nile virus serological assays in thirteen seroconversion panels.
Tobler LH, Shyamala V, Saldanha J, Cameron C, Lanciotti R, Smith R, Munneke B, Walsh I, Phelps BH, Chien D,
Busch MP. West Nile virus (WNV) viral load comparison study.
